Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Outcome Measure:

safety and efficacy

Outcome Time Frame:

10 years

Safety Issue:

No

Principal Investigator

Naeem Chaudhri, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

King Faisal Specialist Hospital & Research Centre

Authority:

United States: Institutional Review Board

Study ID:

RAC #2051-057

NCT ID:

NCT00538278

Start Date:

October 2007

Completion Date:

October 2020

Related Keywords:

• Leukemia, Myeloblastic, Acute
• AML
• Leukemia
• Leukemia, Myeloid, Acute

Name	Location